Guest Speaker

Please join us December 5th for a special presentation on HSV Vaccines and what is in the pipeline! Dr. Simon Delagrave Simon is a life sciences R&D executive, consultant, and board member whose 28 years of professional experience span infectious diseases and gene therapy, deploying various technologies such as viral vectors, vaccines, antibodies, structural biology,Continue reading "Dr. Simon Delagrave: The HSV Vaccine Pipeline Needs New Ideas – a More Technical Discussion of HSV Vaccinology"

View Recording Here Dr. Jia Zhu is a research professor at the University of Washington Laboratory Medicine and Pathology. Her research studies the tissue-based immune response to herpes simplex virus (HSV) infection in humans. She has spent most of her career focused on understanding intricate interactions between HSV and the local immune responses in humanContinue reading "Understanding the Immune Battlefields of Genital Herpes"

Dr. Shafat-Fainguelernt is an internal medicine physician and infectious disease specialist from Israel. She graduated from Ben Gurion University Medical School and received further training at the Soroka University Medical Center in Beer Sheva, Israel. Since 2017, she has been an instructor at the Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheba,Continue reading "The Immunocompromised Patient and Acyclovir-Resistance"

In partnership with HVTN, Dr. Betsy Harold will lead this talk. Herpes simplex virus type 2 (HSV-2) is one of the most significant factors fueling the global HIV epidemic andContinue reading "Dr. Betsy Harold – Disrupting the HSV:HIV Syndemic"

Laura Gillim, Phd is Medical Science Liaison, Infectious Disease at Labcorp and a Discipline Director for Infectious Disease Immunology. Laura was previously a scientific director in the department of science and technology and technical director for the Labcorp Denver regional laboratory. Prior to joining Labcorp, Laura served as the CLIA laboratory director for the ColoradoContinue reading "HSV Laboratory Testing:  Challenges and Limitations"

We’re excited to announce the release of the Herpes Cure Pipeline 4.0! Join us for the release as we dive into the pipeline. Thank you for your continued patience and support as we worked to bring you the most up-to-date and accurate information. Register Here

View Slide Deck from Presentation Dr. Adva Gadoth is the Associate Director of Epidemiology of Infectious Diseases for Moderna’s early stage and latent virus vaccines, including herpes simplex virus (HSV), cytomegalovirus (CMV), and mpox clinical development programs. Adva also supports epidemiologic evidence generation and non-interventional study implementation for Moderna’s global public health efforts, building offContinue reading "Updates in Genital Herpes Epidemiology: Prevalence of Diagnosis and Antiviral Treatment Use in the United States"

View Recording Dr. Marius Walter is a virologist and molecular biologist at the Fred Hutch Cancer Center in Seattle, WA. His research focuses on herpesviruses and invented a new therapeuticContinue reading "HSV Updates – Fred Hutch"

Join us for a powerful and honest conversation bridging the gap between healthcare professionals and the herpes patient community. This unique panel brings together leading voices in HSV education, advocacy,Continue reading "HSV Patient-Provider Panel"

Join us as we host Assembly Bio for an in-depth discussion on recurrent genital herpes (RGH). This talk will provide an overview of RGH epidemiology, real-world disease burden, and impactContinue reading "Assembly Bio: Redefining the Treatment of Recurrent Genital Herpes Through Long-Acting Innovation."